
|Articles|October 1, 1997 (Updated: November 11, 2020)
Oncology NEWS International
- Oncology NEWS International Vol 6 No 10
- Volume 6
- Issue 10
A Picture of Prostate Cancer in Europe
HAMBURG-The Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
Advertisement
HAMBURGThe Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
- In Europe, one man in 11 is diagnosed with prostate cancer, which accounts for 13% of all new cancer diagnoses and almost 9% of cancer deaths.
- The death rate tends to be highest in northern European countries and lowest in southern and eastern Europe.
- Death rates from prostate cancer have risen dramatically in recent years, probably because of the increasing number of elderly men in the population. In England and Wales, for example, there were 4,313 deaths attributed to prostate cancer in 1974, compared with 8,735 in 1992, a 103% increase in only 17 years.
Articles in this issue
over 28 years ago
Toremifene, Tamoxifen Equivalent in Advanced Breast Cancerover 28 years ago
Fluorescence ‘LIFE’ Images Spot Occult Lung Cancer Lesionsover 28 years ago
The Issue That Won’t Go Away: Screening Mammographyover 28 years ago
News in Brief...over 28 years ago
Concurrent Better Than Sequential Chemo-RT in NSCLCover 28 years ago
Consumer Version of Merck & Co’s Famous Manual Is Availableover 28 years ago
A Talk With Dr. Richard Klausner, Head of the NCIover 28 years ago
Age Is a Factor in Survival of SqCC of the Head and Neckover 28 years ago
Symptom-Based Staging of Head & Neck CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement



PSMA PET/CT–Guided Radiation Exhibits Favorable Prostate Cancer Outcomes
Published: | Updated:


Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
2
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma
3
Where Does KEYNOTE-B96 Regimen Fit in Pretreated Ovarian Cancer?
4
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC?
5






































